
Elizabeth Katherine Speliotes MD
Assistant Professor, Internal Medicine, University of Michigan Medical School
Join to View Full Profile
1500 E Medical Center Dr3rd Floor Taubman Center Recp DAnn Arbor, MI 48109
Phone+1 734-647-5944
Dr. Speliotes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 2004 - 2007
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2002 - 2004
- Harvard Medical SchoolClass of 2002
Certifications & Licensure
- MI State Medical License 2010 - 2027
- MA State Medical License 2005 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment.Vincent L Chen, Annapurna Kuppa, Antonino Oliveri, Yanhua Chen, Prabhu Ponnandy
The Journal of Clinical Investigation. 2025-04-01 - Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening.Taslima G Khan, Juliana Bragazzi Cunha, Chinmay Raut, Michael Burroughs, Hitarthi S Vyas
Atherosclerosis. 2025-03-22 - PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease.Elizabeth K Speliotes, Carolin Victoria Schneider
Liver International. 2025-03-01
Journal Articles
- HSD17B13 Is a Hepatic Retinol Dehydrogenase Associated with Histological Features of Non‐Alcoholic Fatty Liver DiseaseElizabeth K Speliotes, Arun J Sanyal, Hepatology
- A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver DiseaseElizabeth K Speliotes, Philip Greenland, Daniel Levy, Lisa B VanWagner, Michelle T Long, Diabetes Care
- Genome-Wide Association Analyses Identify 39 New Susceptibility Loci for Diverticular DiseaseElizabeth Speliotes, MD, Nature
Press Mentions
- Highlights from DDWJuly 22nd, 2022
- New Study Suggests Excess Glycogen May Cause Metabolic SyndromeFebruary 19th, 2021
- Genome-Wide Study Identifies Genes Linked to Diverticular DiseaseSeptember 3rd, 2018
- Join now to see all
Grant Support
- Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver DiseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
- Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver DiseaseWAKE FOREST UNIVERSITY HEALTH SCIENCES2021–2025
- Analysis Of Fatty Liver In The Framingham Heart Study CohortNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
- Analysis Of Fatty Liver In The Framingham Heart Study CohortNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
- Analysis Of Fatty Liver In The Framingham Heart Study CohortNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: